No Data
No Data
Scotiabank Maintains Biomea Fusion(BMEA.US) With Buy Rating, Maintains Target Price $21
Biomea Fusion, Inc. (BMEA): Why Did Analysts Give This Biotech Penny Stock a Moderate Buy Rating?
Rodman & Renshaw Downgrades Biomea Fusion(BMEA.US) to Hold Rating, Cuts Target Price to $9
H.C. Wainwright Maintains Biomea Fusion(BMEA.US) With Buy Rating, Cuts Target Price to $15
Express News | HC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $15 Price Target
Biomea Fusion, Inc. (BMEA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings